Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical passes the values gate
Price40.44 USD
Fair value39.77
Ethical score70.0/100
Our investment reviews on this name
2026-08-22Read Markup45.69-11.5% to today
2026-07-02Read Distribution37.76+7.1% to today
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Avient Corporation holds its Markdown at $40.44. Elevated stress, defensive posture warranted, held for 10 days.
As held on the ledger · 2026-09-21
Phase
Markdown · caution
Quantitative state
Elevated stress, defensive posture warranted, held for 10 days
Price at the screen
$40.44
Valuation
21.86 trailing · 11.57 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.31
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
33.20%
Below 33%
Interest-bearing debt is just 33.2% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
15.69%
Below 49%
Money owed to the company is 15.7% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-21 screen. The gold marker is the market price at the same screen. The price runs 1.7% above the base estimate.
Third-party analyst targets: 7 covering, consensus None. The average target sits +24% from the screen price.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-21 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Chemicals Maker Shows The Classic Cycle Trap
Walk into any factory making plastic parts for cars or packaging and the price of those coloured pellets swings hard with the economy. Avient sits right in that flow, mixing additives and engineered materials that only sell well when demand is strong. At 10.9 times forward earnings the shares look inexpensive next to the analyst target of 47 dollars, yet revenue growth of just 2 percent, a 5 percent profit margin and 7 percent return on equity tell a different story. We pass.
The business clears our ethical screen with no obvious red flags on labour or environment. Margins and returns remain modest even after the recent price dip to 36.97 dollars against our fair value of 37.80, leaving almost no margin of safety. Low growth and thin profitability leave little room for the surprises that usually hit specialty chemical firms.
Because this is a cyclical industry the low multiple is not a bargain but a warning. Peak earnings often coincide with the lowest valuations, and any slowdown in autos or construction could quickly erase the apparent cheapness. Analysis, not advice.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
AVNT trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-22Markup · changed$45.69+23.6%Entry 5
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 23.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (7 analysts) rates it buy, with a mean price target of $48.
2026-07-22Distribution$36.97-2.1%Entry 4
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (7 analysts) rates it buy, with a mean price target of $48.
2026-07-18Distribution$37.76+0.0%Entry 3
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (7 analysts) rates it buy, with a mean price target of $48.
2026-07-03Distribution$37.76+0.0%Entry 2
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02Distribution$37.76Entry 1
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
